Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need.
Prolexys Pharmaceuticals
2150 West Dauntless Avenue
Salt Lake City
UT
84116
801 303 1700
Deal Flow
Fundings
| Closing Date | Round | Amount |
|---|---|---|
| 11/06/2008 | Series A | $20,000,000 |
| 07/30/2008 | Unattributed | $15,000,000 |
| 08/01/2006 | Unattributed | $9,400,000 |
| 04/01/2001 | Seed | $82,000,000 |






